Company news

Share this article:
Pfizer announced that it has entered into a $15 million dollar collaboration with the University of Pennsylvania School of Medicine. The partnership will include collaborations between Pfizer and the university in the areas of scientific research, clinical development and clinical care and policy. Under the terms of the agreement, Pfizer will pay Penn $15 million over a three-year period, during which time scientists from Pfizer and Penn's School of Medicine will work together on several projects of mutual interest including basic and translational research addressing several therapeutic areas. Project proposals will be solicited and reviewed by a committee with representation from both parties. The initial emphasis of the collaboration will focus on the neurosciences and oncology, but may expand to other areas, Pfizer said in a statement.

Omnicom's digital and CRM-intensive STAR Marketing network launched a healthcare offering. STAR Healthcare will offer “integrated, personalized” direct to patient programs under the guidance of managers to be announced in two unique positions: those of “patient advocate” and “client champion.”

Ketchum launched Well Connected, a “cross-practice health and wellness specialty” aimed at leveraging the shop's expertise in health and wellness, influencer relationships and proprietary research in food and nutrition, healthcare and brand. In addition to research, the practice also offers clients a partnership with the National Senior Games Association and supermarket and branding expert Phil Lempert.  
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.